down arrow

Shanghai Pharmaceuticals Holding Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000012B3
HKD
11.95
0.18 (1.53%)

Dec 12

HKG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
The United Laboratories International Holdings Ltd.
China Medical System Holdings Ltd.
Grand Pharmaceutical Group Ltd.
Simcere Pharmaceutical Group Ltd.
Hygeia Healthcare Holdings Co., Ltd.
Luye Pharma Group Ltd.
SSY Group Ltd.
China Traditional Chinese Medicine Holdings Co. Ltd.
Shanghai Pharmaceuticals Holding Co., Ltd.
HUTCHMED (China) Ltd.
Keymed Biosciences, Inc.
Why is Shanghai Pharmaceuticals Holding Co., Ltd. ?
1
High Debt company with Weak Long Term Fundamental Strength
  • Poor long term growth as Operating profit has grown by an annual rate 0.64% of over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
2
Flat results in Dec 19
  • DEBT-EQUITY RATIO (HY) Highest at 46.22 %
3
With ROE of 9.56%, it has a Very Expensive valuation with a 0.14 Price to Book Value
  • The stock is trading at a fair value compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -11.09%, its profits have risen by 40.4% ; the PEG ratio of the company is 0
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -11.09% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shanghai Pharmaceuticals Holding Co., Ltd. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Shanghai Pharmaceuticals Holding Co., Ltd.
-11.09%
-0.16
21.25%
Hang Seng Hong Kong
27.36%
1.06
25.88%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
7.97%
EBIT Growth (5y)
0.64%
EBIT to Interest (avg)
4.71
Debt to EBITDA (avg)
1.73
Net Debt to Equity (avg)
0.20
Sales to Capital Employed (avg)
2.17
Tax Ratio
29.24%
Dividend Payout Ratio
30.34%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
10.03%
ROE (avg)
10.26%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
1
Industry P/E
Price to Book Value
0.14
EV to EBIT
4.06
EV to EBITDA
2.95
EV to Capital Employed
0.31
EV to Sales
0.11
PEG Ratio
0.04
Dividend Yield
NA
ROCE (Latest)
7.76%
ROE (Latest)
9.56%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for Shanghai Pharmaceuticals Holding Co., Ltd.
Operating Cash Flow
Highest at HKD 4,300.33 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (HKD MM)

Interest Coverage Ratio
Highest at 724.55
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Raw Material Cost
Fallen by -11.05% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at HKD 1,213.44 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Depreciation
At HKD 1,213.44 MM has Grown at 11.42%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for Shanghai Pharmaceuticals Holding Co., Ltd.
Debt-Equity Ratio
Highest at 46.22 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."